VITAS Outpaces Q2 Expectations and Eyes Acquisitions for Hospice Growth

VITAS Healthcare reported stronger-than-expected second-quarter 2026 results, supported by higher admissions, lower-than-planned hospice costs and improved performance in Florida. The hospice and palliative care provider also raised its full-year outlook and said it is evaluating acquisitions that could support expansion despite a federal enrollment moratorium.

Key takeaways

• VITAS revenue increased $47.1 million, or 11.9%, during the quarter.

• Net income rose 59% to $60.9 million.

• Florida’s Medicare cap billing issue was substantially reduced from the prior year.

• VITAS is reviewing acquisitions involving providers that meet the federal 36-month rule.

The results offer several planning considerations for smaller hospice and home care operators. Accurate bookkeeping, cost reporting and cash-flow analysis remain essential when reimbursement rules and acquisition conditions are changing.

Revenue growth exceeds expectations

VITAS, the nation’s largest hospice and palliative care provider, attributed its performance to accelerated admissions from nonhospital referral sources, continued strength in hospital-based admissions and lower-than-budgeted hospice costs. Company leadership said the quarter exceeded the high end of its expectations.

The company also cited a balance between hospital pre-admissions, community- and home-based patients, and longer patient stays as factors supporting margin expansion through the remainder of the year. For operators in the Chicagoland market, these trends reinforce the importance of monitoring referral mix, length of stay, labor costs and service-line profitability through timely financial reporting.

Florida billing issue shows improvement

VITAS recorded $500,000 in Medicare cap billing limitation during the second quarter, compared with $16.4 million in the same quarter of 2025. Executives said the improvement indicates that the prior-year Florida issue has been resolved and that the business has returned to a more normalized growth rate.

Medicare cap exposure can materially affect hospice revenue and financial forecasts. Providers should maintain disciplined cost report filing, reimbursement reviews and reserve analysis. Specialized accounting support can help identify emerging exposure before it affects operating decisions or year-end tax planning.

Moratorium shapes acquisition strategy

A six-month nationwide Centers for Medicare & Medicaid Services moratorium on new hospice and home health Medicare enrollees is limiting VITAS’s ability to seek new certificates of need. However, company executives said the restriction does not prevent acquisitions of existing providers that have been operating and billing the federal government for at least three years.

VITAS is particularly interested in markets with barriers to entry, while continuing to assess other opportunities. Any transaction requires careful review of historical financial statements, payroll obligations, Medicare reporting, compliance risks and working capital needs. Fractional CFO and consulting services can provide smaller providers with transaction modeling and due diligence support before a sale or partnership advances.

Outlook for hospice operators

VITAS increased its full-year guidance after the strong quarter and plans to pursue high, sustainable growth while maintaining patient and family care standards. Its results may encourage additional consolidation across hospice and home-based care, especially where regulatory barriers make existing providers more valuable.

For independent operators, the near-term priority is financial visibility. Reliable bookkeeping, payroll controls, tax preparation and cost report filing can strengthen decision-making whether the goal is organic growth, acquisition readiness or long-term succession planning.

Sources

• VITAS exceeds growth expectations in Q2, looks to make acquisitions, McKnights Home Care.